AU2002223313A1 - Protease inhibitors and their pharmaceutical uses - Google Patents

Protease inhibitors and their pharmaceutical uses

Info

Publication number
AU2002223313A1
AU2002223313A1 AU2002223313A AU2331302A AU2002223313A1 AU 2002223313 A1 AU2002223313 A1 AU 2002223313A1 AU 2002223313 A AU2002223313 A AU 2002223313A AU 2331302 A AU2331302 A AU 2331302A AU 2002223313 A1 AU2002223313 A1 AU 2002223313A1
Authority
AU
Australia
Prior art keywords
protease inhibitors
pharmaceutical uses
pharmaceutical
protease
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223313A
Inventor
Octavio Augusto Ceva Antunes
Vera Bongertz
Rodrigo De Moraes Brindeiro
Luciana J. O. Figueiredo
Emerson Poley Pecanha
Amilcar Tanuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacao Oswaldo Cruz
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Publication of AU2002223313A1 publication Critical patent/AU2002223313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2002223313A 2000-11-23 2001-11-22 Protease inhibitors and their pharmaceutical uses Abandoned AU2002223313A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0005525-5 2000-11-23
BR0005525-5A BR0005525A (en) 2000-11-23 2000-11-23 Protease inhibitors and their pharmaceutical uses
PCT/BR2001/000141 WO2002042412A2 (en) 2000-11-23 2001-11-22 Protease inhibitors and their pharmaceutical uses

Publications (1)

Publication Number Publication Date
AU2002223313A1 true AU2002223313A1 (en) 2002-06-03

Family

ID=3945806

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223313A Abandoned AU2002223313A1 (en) 2000-11-23 2001-11-22 Protease inhibitors and their pharmaceutical uses

Country Status (10)

Country Link
US (1) US20030158152A1 (en)
EP (1) EP1335895A2 (en)
JP (1) JP2004513971A (en)
CN (1) CN1406223A (en)
AP (1) AP2002002584A0 (en)
AU (1) AU2002223313A1 (en)
BR (1) BR0005525A (en)
OA (1) OA12164A (en)
WO (1) WO2002042412A2 (en)
ZA (1) ZA200205854B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060264672A1 (en) * 2005-02-23 2006-11-23 Andrews Mark A Processes using alpha, omega-difunctional aldaramides as monomers and crosslinkers
US7351862B2 (en) * 2005-02-23 2008-04-01 E.I. Du Pont De Nemours And Company Alpha, omega-difunctional aldaramides
JP5944314B2 (en) 2009-07-31 2016-07-05 ラトガース，ザ ステート ユニバーシティ オブ ニュー ジャージー Biocompatible polymers for medical devices
EP2486081B1 (en) 2009-10-11 2018-12-05 Rutgers, The State University of New Jersey Biocompatible polymers for medial devices
CA3069030C (en) 2012-02-03 2021-11-16 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
US11472918B2 (en) 2012-02-03 2022-10-18 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
CN104211666B (en) * 2013-05-31 2017-11-14 中国人民解放军军事医学科学院毒物药物研究所 2,3 epoxy succinyl aminated compounds, preparation method and use
US10774030B2 (en) 2014-12-23 2020-09-15 Rutgers, The State University Of New Jersey Polymeric biomaterials derived from phenolic monomers and their medical uses
WO2016103224A2 (en) 2014-12-23 2016-06-30 Rutgers, The State University Of New Jersey Biocompatible iodinated diphenol monomers and polymers
EP3286174A1 (en) * 2015-04-23 2018-02-28 VIIV Healthcare UK (No.5) Limited Inhibitors of human immunodeficiency virus replication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855297A (en) * 1971-03-10 1974-12-17 Sterling Drug Inc 1,1{40 -bridged-bis{8 n-(alkyl)-2-aminoethanols{9

Also Published As

Publication number Publication date
ZA200205854B (en) 2003-10-22
OA12164A (en) 2006-05-08
US20030158152A1 (en) 2003-08-21
EP1335895A2 (en) 2003-08-20
BR0005525A (en) 2003-09-02
WO2002042412A2 (en) 2002-05-30
CN1406223A (en) 2003-03-26
AP2002002584A0 (en) 2002-09-30
JP2004513971A (en) 2004-05-13
WO2002042412A3 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
HUP0300855A3 (en) Peptidmomimetic protease inhibitors, pharmaceutical compositions and their use
AU2001265008A1 (en) Caspase inhibitors and uses thereof
HUP0300720A3 (en) Serine protease inhibitors, pharmaceutical compositions containing them and their use
AU2001258771A1 (en) -secretase inhibitors
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2003221786A1 (en) Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
AU2001280188A1 (en) Pyrazolopyridine compound and pharmaceutical use thereof
AU6007200A (en) Cysteine protease inhibitors
AU2002230836A1 (en) Benzylamine derivatives and their use as thrombin inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2002230385A1 (en) Peptide deformylase inhibitors
AU2002216649A1 (en) Benzoxazole lpaat- beta inhibitors and uses thereof
AU2002211717A1 (en) Stresscopins and their uses
AU2001294557A1 (en) Thrombin inhibitors
AU6536200A (en) Proteases and protease inhibitors
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2002223313A1 (en) Protease inhibitors and their pharmaceutical uses
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001241498A1 (en) Matrix metalloproteinase inhibitors and uses thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU1588901A (en) Protease inhibitors
AU2001232809A1 (en) Gyrase inhibitors and uses thereof
AU1474801A (en) Protease inhibitors
AU1039801A (en) Compounds and their use as cysteine protease inhibitors